Boryung
003850.KO
7.21 USD
-0.13
-1.77%
b
Overview
Last close
7.21 usd
Market cap
605.70M usd
52 week high
10.04 usd
52 week low
5.92 usd
Target price
10.7 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.9167
Price/Book Value
1.4212
Enterprise Value
719.73M usd
EV/Revenue
1.0181
EV/EBITDA
9.2654
Key financials
Revenue TTM
662.23M usd
Gross Profit TTM
219.04M usd
EBITDA TTM
80.47M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
1,029.65B usd
Net debt
N/A usd
About
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
- Symbol003850.KO
- ExchangeKO
- IsinKR7003850005
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Jay Kim
- HeadquarterSeoul
- Web sitehttps://www.boryung.co.kr
